| Authors: |
Brück K; Department of Radiotherapy, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Netherlands Comprehensive Cancer Organization, Nijmegen, The Netherlands. Electronic address: k.brueck@amsterdamumc.nl., Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands., Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., van Hoogstraten LMC; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Netherlands Comprehensive Cancer Organization, Nijmegen, The Netherlands., van der Heijden MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Donders AR; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Franckena M; Department of Radiotherapy, Erasmus MC, Rotterdam, The Netherlands., Uyl de Groot CA; Institute for Medical Technology Assessment, Rotterdam, The Netherlands; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands., Leliveld AM; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands., Aben KKH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Netherlands Comprehensive Cancer Organization, Nijmegen, The Netherlands., Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Centers, Amsterdam, The Netherlands. |
